Opinion Article
The Human Papillomavirus Vaccine: Is it of Value in Dermatology?
La vacuna frente al papilomavirus humano, ¿tiene interés en dermatología?
Leído
8062
Vecesse ha leído el artículo
2333
Total PDF
5729
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 13 | 3 | 16 |
| 2025 5 | 94 | 26 | 120 |
| 2025 4 | 133 | 28 | 161 |
| 2025 3 | 111 | 15 | 126 |
| 2025 2 | 109 | 31 | 140 |
| 2025 1 | 69 | 25 | 94 |
| 2024 12 | 78 | 20 | 98 |
| 2024 11 | 88 | 39 | 127 |
| 2024 10 | 63 | 34 | 97 |
| 2024 9 | 58 | 14 | 72 |
| 2024 8 | 97 | 41 | 138 |
| 2024 7 | 80 | 21 | 101 |
| 2024 6 | 90 | 35 | 125 |
| 2024 5 | 71 | 29 | 100 |
| 2024 4 | 86 | 25 | 111 |
| 2024 3 | 71 | 36 | 107 |
| 2024 2 | 52 | 29 | 81 |
| 2024 1 | 52 | 44 | 96 |
| 2023 12 | 56 | 17 | 73 |
| 2023 11 | 74 | 29 | 103 |
| 2023 10 | 66 | 17 | 83 |
| 2023 9 | 52 | 31 | 83 |
| 2023 8 | 43 | 14 | 57 |
| 2023 7 | 46 | 32 | 78 |
| 2023 6 | 67 | 15 | 82 |
| 2023 5 | 55 | 26 | 81 |
| 2023 4 | 50 | 20 | 70 |
| 2023 3 | 70 | 23 | 93 |
| 2023 2 | 60 | 22 | 82 |
| 2022 1 | 60 | 28 | 88 |
| 2022 12 | 56 | 37 | 93 |
| 2022 11 | 28 | 23 | 51 |
| 2022 10 | 39 | 34 | 73 |
| 2022 9 | 36 | 31 | 67 |
| 2022 8 | 24 | 31 | 55 |
| 2022 7 | 29 | 26 | 55 |
| 2022 6 | 20 | 22 | 42 |
| 2022 5 | 36 | 24 | 60 |
| 2022 4 | 51 | 51 | 102 |
| 2022 3 | 47 | 56 | 103 |
| 2022 2 | 52 | 23 | 75 |
| 2021 1 | 44 | 36 | 80 |
| 2021 12 | 35 | 48 | 83 |
| 2021 11 | 56 | 33 | 89 |
| 2021 10 | 41 | 46 | 87 |
| 2021 9 | 37 | 40 | 77 |
| 2021 8 | 57 | 27 | 84 |
| 2021 7 | 29 | 30 | 59 |
| 2021 6 | 39 | 31 | 70 |
| 2021 5 | 50 | 40 | 90 |
| 2021 4 | 109 | 42 | 151 |
| 2021 3 | 70 | 25 | 95 |
| 2021 2 | 52 | 32 | 84 |
| 2020 1 | 39 | 23 | 62 |
| 2020 12 | 26 | 17 | 43 |
| 2020 11 | 27 | 22 | 49 |
| 2020 10 | 34 | 9 | 43 |
| 2020 9 | 38 | 14 | 52 |
| 2020 8 | 30 | 24 | 54 |
| 2020 7 | 28 | 18 | 46 |
| 2020 6 | 36 | 21 | 57 |
| 2020 5 | 22 | 18 | 40 |
| 2020 4 | 30 | 19 | 49 |
| 2020 3 | 31 | 17 | 48 |
| 2020 2 | 4 | 1 | 5 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 4 | 3 | 7 |
| 2019 11 | 0 | 3 | 3 |
| 2019 9 | 4 | 0 | 4 |
| 2019 7 | 0 | 8 | 8 |
| 2019 6 | 2 | 5 | 7 |
| 2019 5 | 1 | 18 | 19 |
| 2019 4 | 0 | 1 | 1 |
| 2019 3 | 2 | 5 | 7 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 4 | 0 | 4 |
| 2018 10 | 6 | 0 | 6 |
| 2018 9 | 2 | 0 | 2 |
| 2018 7 | 0 | 1 | 1 |
| 2018 5 | 0 | 2 | 2 |
| 2018 3 | 2 | 0 | 2 |
| 2018 2 | 28 | 1 | 29 |
| 2018 1 | 43 | 8 | 51 |
| 2017 12 | 44 | 8 | 52 |
| 2017 11 | 43 | 3 | 46 |
| 2017 10 | 49 | 7 | 56 |
| 2017 9 | 42 | 2 | 44 |
| 2017 8 | 71 | 7 | 78 |
| 2017 7 | 63 | 11 | 74 |
| 2017 6 | 51 | 16 | 67 |
| 2017 5 | 44 | 10 | 54 |
| 2017 4 | 39 | 7 | 46 |
| 2017 3 | 24 | 7 | 31 |
| 2017 2 | 22 | 13 | 35 |
| 2016 1 | 26 | 12 | 38 |
| 2016 12 | 41 | 6 | 47 |
| 2016 11 | 58 | 4 | 62 |
| 2016 10 | 44 | 19 | 63 |
| 2016 9 | 49 | 6 | 55 |
| 2016 8 | 64 | 13 | 77 |
| 2016 7 | 44 | 11 | 55 |
| 2016 6 | 11 | 16 | 27 |
| 2016 5 | 4 | 0 | 4 |
| 2016 4 | 4 | 7 | 11 |
| 2016 3 | 9 | 1 | 10 |
| 2016 2 | 12 | 2 | 14 |
| 2015 1 | 7 | 4 | 11 |
| 2015 12 | 11 | 0 | 11 |
| 2015 11 | 14 | 2 | 16 |
| 2015 10 | 15 | 3 | 18 |
| 2015 9 | 9 | 1 | 10 |
| 2015 8 | 8 | 2 | 10 |
| 2015 7 | 38 | 7 | 45 |
| 2015 6 | 44 | 4 | 48 |
| 2015 5 | 77 | 6 | 83 |
| 2015 4 | 65 | 9 | 74 |
| 2015 3 | 64 | 9 | 73 |
| 2015 2 | 47 | 11 | 58 |
| 2015 1 | 39 | 11 | 50 |
| 2014 12 | 48 | 8 | 56 |
| 2014 11 | 41 | 8 | 49 |
| 2014 10 | 47 | 19 | 66 |
| 2014 9 | 39 | 10 | 49 |
| 2014 8 | 54 | 17 | 71 |
| 2014 7 | 67 | 23 | 90 |
| 2014 6 | 72 | 12 | 84 |
| 2014 5 | 69 | 12 | 81 |
| 2014 4 | 56 | 10 | 66 |
| 2014 3 | 68 | 23 | 91 |
| 2014 2 | 18 | 7 | 25 |
| 2014 1 | 19 | 6 | 25 |
| 2013 12 | 31 | 8 | 39 |
| 2013 11 | 21 | 10 | 31 |
| 2013 10 | 26 | 9 | 35 |
| 2013 9 | 22 | 4 | 26 |
| 2013 8 | 11 | 3 | 14 |
| 2013 7 | 10 | 11 | 21 |
| 2013 6 | 10 | 13 | 23 |
| 2013 5 | 13 | 9 | 22 |
| 2013 4 | 18 | 9 | 27 |
| 2013 3 | 12 | 7 | 19 |
| 2013 2 | 30 | 5 | 35 |
| 2013 1 | 18 | 4 | 22 |
| 2012 12 | 14 | 5 | 19 |
| 2012 11 | 0 | 2 | 2 |
| 2012 10 | 3 | 5 | 8 |
Mostrar todo
